Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing
暂无分享，去创建一个
C. Mattiuzzi | G. Salvagno | S. De Nitto | B. Henry | L. Pighi | G. Lippi
[1] G. Lippi,et al. Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays , 2023, Clinical chemistry and laboratory medicine.
[2] G. Lippi,et al. Uncontrolled confounding in COVID-19 epidemiology , 2022, Diagnosis.
[3] G. Lippi,et al. Timeline analysis of clinical severity of COVID-19 in the general population , 2022, European Journal of Internal Medicine.
[4] G. Lippi,et al. Clinical Chemistry and Laboratory Medicine celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2 , 2022, Clinical chemistry and laboratory medicine.
[5] M. Bazyar,et al. Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review , 2022, International Journal of Surgery.
[6] G. Lippi,et al. Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group , 2022, Clinical chemistry and laboratory medicine.
[7] G. Lippi,et al. Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay , 2021, EJIFCC.
[8] G. Lippi,et al. Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals , 2021, Diagnosis.